{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:23:16Z","timestamp":1762615396383,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtm.2025.101516","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T15:49:17Z","timestamp":1750261757000},"page":"101516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protection from malaria infection using liver-targeted siRNA"],"prefix":"10.1016","volume":"33","author":[{"given":"R.W.J.","family":"Steel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schepis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Milstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Yucius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C.","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fishilevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Haslett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.I.","family":"Kappe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2023","series-title":"World Malaria Report 2023","key":"10.1016\/j.omtm.2025.101516_bib1"},{"key":"10.1016\/j.omtm.2025.101516_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.pt.2021.01.008","article-title":"Secretory Organelle Function in the Plasmodium Sporozoite","volume":"37","author":"Arredondo","year":"2021","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.omtm.2025.101516_bib3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jhep.2021.05.034","article-title":"Malaria parasite liver stages","volume":"76","author":"Goswami","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtm.2025.101516_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41579-019-0306-2","article-title":"Plasmodium asexual growth and sexual development in the haematopoietic niche of the host","volume":"18","author":"Venugopal","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.omtm.2025.101516_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","article-title":"Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial","volume":"403","author":"Datoo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101516_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101516_bib7","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41590-024-01938-2","article-title":"Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention","volume":"25","author":"Wang","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtm.2025.101516_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25903","article-title":"Plasmodium P36 determines host cell receptor usage during sporozoite invasion","volume":"6","author":"Manzoni","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.omtm.2025.101516_bib9","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/cmi.12309","article-title":"CD81 is required for rhoptry discharge during host cell invasion by Plasmodium yoelii sporozoites","volume":"16","author":"Risco-Castillo","year":"2014","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.omtm.2025.101516_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm808","article-title":"Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity","volume":"9","author":"Silvie","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101516_bib11","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1038\/s41467-021-27109-7","article-title":"Plasmodium sporozoite phospholipid scramblase interacts with mammalian carbamoyl-phosphate synthetase 1 to infect hepatocytes","volume":"12","author":"Cha","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101516_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.704662","article-title":"The Host Protein Aquaporin-9 is Required for Efficient Plasmodium falciparum Sporozoite Entry into Human Hepatocytes","volume":"11","author":"Amanzougaghene","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.omtm.2025.101516_bib13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.aad3318","article-title":"Malaria parasites target the hepatocyte receptor EphA2 for successful host infection","volume":"350","author":"Kaushansky","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101516_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fcimb.2018.00413","article-title":"The Micronemal Plasmodium Proteins P36 and P52 Act in Concert to Establish the Replication-Permissive Compartment Within Infected Hepatocytes","volume":"8","author":"Arredondo","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.omtm.2025.101516_bib15","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1462-5822.2006.00697.x","article-title":"Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species","volume":"8","author":"Silvie","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.omtm.2025.101516_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrg3978","article-title":"Knocking down disease: a progress report on siRNA therapeutics","volume":"16","author":"Wittrup","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtm.2025.101516_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2025.101516_bib18","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.omtm.2025.101516_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2208391","article-title":"Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension","volume":"389","author":"Desai","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101516_bib20","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101516_bib21","article-title":"Quantitative bioluminescent imaging of pre-erythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii","volume":"8","author":"Miller","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101516_bib22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/jama.2024.0728","article-title":"RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial","volume":"331","author":"Bakris","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2025.101516_bib23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamacardio.2019.3502","article-title":"Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial","volume":"4","author":"Ray","year":"2019","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.omtm.2025.101516_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nmeth.3432","article-title":"Plasmodium falciparum genetic crosses in a humanized mouse model","volume":"12","author":"Vaughan","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2025.101516_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.molbiopara.2012.10.004","article-title":"A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle","volume":"186","author":"Vaughan","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.omtm.2025.101516_bib26","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of Artemisinin-Resistant Malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101516_bib27","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/14760584.2023.2245890","article-title":"Sporozoite immunization: innovative translational science to support the fight against malaria","volume":"22","author":"Richie","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omtm.2025.101516_bib28","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(23)02892-1","article-title":"First-generation malaria vaccine successfully implemented in three African countries","volume":"403","author":"Daubenberger","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101516_bib29","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/jac\/dkv019","article-title":"Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model","volume":"70","author":"Foquet","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.omtm.2025.101516_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000010","article-title":"Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain","volume":"4","author":"Yalaoui","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtm.2025.101516_bib31","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI39748","article-title":"CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency","volume":"120","author":"van Zelm","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101516_bib32","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.185.8.1505","article-title":"Normal lymphocyte development but delayed humoral immune response in CD81-null mice","volume":"185","author":"Maecker","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtm.2025.101516_bib33","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.chom.2021.03.011","article-title":"Partial protection against P. vivax infection diminishes hypnozoite burden and blood-stage relapses","volume":"29","author":"Schafer","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omtm.2025.101516_bib34","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.7150\/thno.91062","article-title":"Lipid nanoparticle encapsulated large peritoneal macrophages migrate to the lungs via the systemic circulation in a model of clodronate-mediated lung-resident macrophage depletion","volume":"14","author":"Oza","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.omtm.2025.101516_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2011.3","article-title":"Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells","volume":"1","author":"Novobrantseva","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2025.101516_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cmi.12817","article-title":"Plasmodium yoelii S4\/CelTOS is important for sporozoite gliding motility and cell traversal","volume":"20","author":"Steel","year":"2018","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.omtm.2025.101516_bib37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1128\/IAI.01249-13","article-title":"Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum","volume":"82","author":"Sack","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.omtm.2025.101516_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41541-017-0028-2","article-title":"Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice","volume":"2","author":"Sack","year":"2017","journal-title":"NPJ Vaccines"}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:21:15Z","timestamp":1762615275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2329050125001111"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101516","relation":{},"ISSN":["2329-0501"],"issn-type":[{"type":"print","value":"2329-0501"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection from malaria infection using liver-targeted siRNA","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101516"}}